✨ Free AI Report
Schrödinger, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Schrödinger, Inc.
Company Research

Schrödinger, Inc.: Business Overview, Financials & Competitive Analysis

Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. The company's software is u...

Analyst-debate audio for Schrödinger, Inc.

AskCyborg analysts argue the bull and bear cases for Schrödinger, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Leading computational drug discovery platform with proven pharma adoption and collaborative R&D pipeline, but facing intensifying...

Read the full analyst-debate transcript →
Industry Drug Discovery Services
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 12, 2026
AI-Verified Research
30+ Page Report

Get the Latest Schrödinger, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Schrödinger, Inc. Overview

Pro stress-test →

Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. The company's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model molecular behavior, accelerating the design and development of new drugs and materials while reducing time and cost to market.

Strategic Profile

Pro stress-test →

The company operates in two segments: Software, which transforms molecular discovery for life sciences and materials science industries, and Drug Discovery, which focuses on building a portfolio of preclinical and clinical programs internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger's technology platform combines physics-based modeling and machine learning to accelerate innovation in pharmaceutical and materials design.

Competitive Landscape

Pro stress-test →

Schrödinger's competitors include Alivexis, Citrine Informatics, Aqemia, Isomorphic Laboratories, Oxford Drug Design, and others. The computational drug discovery space increasingly includes AI-native platforms like Insilico Medicine and InSilicoTrials. Schrödinger maintains differentiation through its physics-based computational approach, established enterprise customer base, and FEP+ gold-standard binding free energy platform.

Industry Context

Schrödinger, Inc. operates in Drug Discovery Services.

Key facts

Founded: 1990 · Headquarters: New York, US · Employees: ~800 · Revenue: N/A · Market cap: $1.08B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Schrödinger, Inc..

  • The majority of the company's revenue is derived from the Software segment.
  • Schrödinger has approximately 800 employees and is engaged with customers and collaborators in more than 70 countries.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2026Schrödinger presenting on materials science applications at UTECH Europe, demonstrating platform capabilities in polymer discovery.
  • May 2024Schrödinger made a later-stage venture investment in Ajax Therapeutics.
  • +1 moreTrack every material event for Schrödinger, Inc. as it happens. Explore monitoring →
Get alerted when Schrödinger, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Isomorphic LaboratoriesAI-driven structure prediction for drug discovery→Insilico MedicineAI platforms for multi-omics target discovery and automated drug design→Citrine InformaticsAI platform for materials discovery and optimization→Recursion PharmaceuticalsComputational biology platform for drug discovery→

Compare Schrödinger, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Schrödinger, Inc. operates in Drug Discovery Services. See how the rest of the sector scores on the Cyborg framework.

Browse Drug Discovery Services research →
NEW · MCP server

Ask your AI assistant about Schrödinger, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Schrödinger, Inc. and its top competitor on Cyborg Score”
“What did Schrödinger, Inc. do this quarter?”
“Is Schrödinger, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Schrödinger, Inc. do?+
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. The company's software is u...
What is Schrödinger, Inc.'s Cyborg Score?+
Schrödinger, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Schrödinger, Inc.'s main competitors?+
Named competitors include Isomorphic Laboratories, Insilico Medicine, Citrine Informatics, Recursion Pharmaceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full Schrödinger, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Schrödinger, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Schrödinger, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.